Inventor · disambiguated record
Musong Kim
Also filed as: KIM MUSONG
25 granted patents·13 pending applications·138 citations·filing 2007–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0296US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 0395US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 0493US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 0592US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 0692US11897862B2IKAROS zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·2 cites·10 claims
- 0792US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 0892US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 0991US10577352B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Granted Mar 3, 2020·10 cites·20 claims
- 1091US10059695B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Aug 28, 2018·12 cites·28 claims
- 1191US9765060B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Sep 19, 2017·13 cites·2 claims
- 1291US9499523B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Nov 22, 2016·14 cites·32 claims
- 1389US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 1488US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 1587US9221795B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Dec 29, 2015·9 cites·59 claims
- 1685US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1785US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1882US9266878B2Phosphatidylinositol 3-kinase inhibitorsEVARTS JERRY·Filed 2015·Granted Feb 23, 2016·7 cites·17 claims
- 1979US2025382278A1Ikaros zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2078US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
- 2177US9018221B2Phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2013·Granted Apr 28, 2015·3 cites·13 claims
- 2276US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 2375US12358887B2IKAROS Zinc Finger Family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 2469US2019248807A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2566US2018237455A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2661US2017008905A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2761US2024124412A1Ikaros zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2859US12122764B2IKAROS zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Oct 22, 2024·0 cites·32 claims
- 2948US2009318396A1Corticosteroid linked beta-agonist compounds for use in therapyGILEAD SCIENCES INC·Filed 2009·Application pending·0 cites
- 3048US2018065953A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 3147US2010112061A1Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic BronchitisBAKER WILLIAM·Filed 2007·Application pending·0 cites
- 3247US2013012504A1Bi-functional quinoline analogsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 3347US2010098641A1Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and BronchoconstrictionBAKER WILLIAM·Filed 2007·Application pending·0 cites
- 3446US8367829B2Bi-functional pyrazolopyridine compoundsGILEAD SCIENCES INC·Filed 2011·Granted Feb 5, 2013·0 cites·18 claims
- 3543US8450490B2Bi-functional pyrazolopyridine compoundsBAKER WILLIAM R·Filed 2012·Granted May 28, 2013·0 cites·4 claims
- 3643US2016039793A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 3740US11021467B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 1, 2021·0 cites·17 claims
- 3839US8394829B2Bi-functional quinoline analogsBAKER WILLIAM R·Filed 2011·Granted Mar 12, 2013·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Musong Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →